SkinHealth Systems (SKIN) Debt Ratio (2020 - 2026)

SkinHealth Systems' (SKIN) quarterly Debt Ratio came in at 0.21 in Q2 2026, down 2.6% quarter-over-quarter from 0.22 in Q1 2026.

Analysis

SkinHealth Systems (SKIN) Debt Ratio (2020 - 2026) Analysis & Trends

SkinHealth Systems (SKIN) has reported Debt Ratio for 3 consecutive years, with 0.21 the latest figure, recorded in Q2 2026.

On a quarterly basis, Debt Ratio changed N/A year-over-year to 0.21 in Q2 2026; TTM through Jun 2026 was 0.21, a N/A change from a year earlier, with the FY2025 full-year figure at 0.25, changed N/A from the prior year.
Debt Ratio was 0.21 for Q2 2026 at SkinHealth Systems, down from 0.22 in the prior quarter.
Over five years, Debt Ratio peaked at 0.25 in Q4 2025 and troughed at 0.21 in Q2 2026.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	187.42 Bn	182.47 Bn	7.27 Bn	0.30
2	Intuitive Surgical	129.78 Bn	124.69 Bn	1.96 Bn	-
3	Medtronic	120.53 Bn	112.33 Bn	6.34 Bn	0.30
4	Stryker	116.28 Bn	112.80 Bn	4.50 Bn	0.31
5	Boston Scientific	69.29 Bn	68.99 Bn	3.85 Bn	0.28
6	Edwards Lifesciences	51.83 Bn	47.68 Bn	1.35 Bn	0.04
7	Alcon	34.36 Bn	32.91 Bn	1.68 Bn	0.13
8	Dexcom	33.17 Bn	31.23 Bn	830.00 Mn	-
9	Steris	21.90 Bn	21.43 Bn	684.20 Mn	0.20
10	SkinHealth Systems	89.77 Mn	-116.30 Mn	49.34 Mn	0.21

Historic Data

Download Data